InMode Ltd.

INMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$14.47

-$0.03 (-0.21%)

Sep 22, 2026, 12:27 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.21%

(1D)

Rating

Updated: Sep 8, 2026

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $831.66M

1D Range

14.43 14.62

52W Range

12.72 16.74

Valuation (TTM)

PE 11.79

PB 1.32

EV/EBITDA 4.00

Valuation (NTM)

Forward PE 10.33

Forward PEG 1.98

Price Target $19

Cash Flow

FCF Yield 10.5%

SBC Adj. FCF Yield 9.8%

SBC Impact -7.1%

Margins

Gross Margin 76.5%

Operating Margin 18.5%

FCF Margin 23.3%

Growth (CAGR)

Revenue 3Y | 5Y -9.0% | 5.4%

Dil EPS 3Y | 5Y -16.9% | -3.9%

FCF 3Y | 5Y -19.8% | -9.4%

Returns

ROA 10.8%

ROE 11.8%

ROIC 9.2%

Financial Health

Net Cash

$501.12M

Current Ratio 8.18

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensi...

Sector Healthcare

Industry Medical - Devices

Employees 660

IPO Date Aug 7, 2019

Website www.inmodemd.com

Fiscal Year January - December

Full Company Profile

Latest News

7 months ago · seekingalpha.com

InMode Ltd. (INMD) Q4 2025 Earnings Call Transcript

7 months ago · prnewswire.com

InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year of 2025.

8 months ago · prnewswire.com

InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT on Wednesday, February 11, 2026.

8 months ago · prnewswire.com

InMode Responds to Transaction Rumors

YOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement: The Company is aware of recent market speculation and rumors, including reports relating to the publicly announced non-binding proposal by Steel Partners Holdings L.P.

Earnings

Next Earnings

Oct 28, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$19

Upside

+31.31%

Buy (1)

Hold (4)

Sell (0)

Analyst Details ➞